Accessibility and reading comfort

Text size

Light/Dark mode

Lines vertical spacing

Trouble using our website?
Contact us

In this page

Clinical Trial

NCT05407636 Recruiting, Active
ASCENT

Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD (ASCENT)

Phase 3
Interventional

Disease

Orphan drug recognition

Yes

Patient type

Adult

Children

Inclusion / Exclusion

Opening date

28/12/2021

Closing date

30/11/2025

Inclusion criteria :

More

Exclusion criteria :

More

Funding

Private

ERN EYE member investigating site

HCP : Principal investigators